Bioretec

7 articles with Bioretec

• Bioresorbable Activa IM-Nail™ shows convincing results in Post-Market Clinical Follow-up study for the treatment of children's forearm fractures

  6/1/2022

  Bioretec Ltd ( HELSINKI : BRETEC)   Forearm fractures are a common injury in children and adolescents.

• Bioretec enters into a distribution agreement with AMI Medical Technologies for bioresorbable Activa products in Israel

  5/12/2022

  Bioretec Ltd has entered into a distribution agreement with AMI Medical Technologies Ltd, a leading distributor of medical devices in Israel.

• Resolutions of Bioretec Ltd´s Annual General Meeting and the organizing meeting of the Board of Directors

  4/13/2022

  The Annual General Meeting of shareholders of Bioretec Ltd was held, 13 April 2022 at 12:00 EEST in Tampere.

• Bioretec Ltd's Annual Report and Financial Statements 2021 published

  3/11/2022

  Bioretec Ltd has published its 2021 Annual Report, Financial Statements and Report by the Board of Directors.

• Bioretec enters into a supply agreement with Meotec for magnesium alloy raw materials for bioresorbable RemeOs products

  1/13/2022

  Bioretec Ltd, a globally operating Finnish medical device company and a pioneer in bioresorbable orthopedic implants, has entered into a raw material supply agreement with Meotec GmbH, a German manufacturer of implantable materials.

• Bioretec files for CE mark for its bioresorbable RemeOs magnesium screw in the EU

  12/31/2021

  Bioretec Ltd, a pioneer in bioresorbable orthopedic implants, has submitted an application for the CE mark for the first product in its new RemeOs™ product family, the RemeOs™ trauma screw.

• Tornier and Bioretec Announce Partnership in Bioresorbable Orthopedic Products

  3/15/2007